Pulmonary Hypertension - Pipeline Review, H2 2015

1
Pulmonary Hypertension - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Pulmonary Hypertension
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Pulmonary
  Hypertension and enlists all their major and
  minor projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Pulmonary Hypertension products
  under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Pulmonary Hypertension pipeline
  on the basis of target, MoA, route of
  administration and molecule type
• Latest news and deals relating related to
  pipeline products
• Read More At http//www.researchbeam.com/pulmona
  ry-hypertension-pipeline-review-h2-2015-market

3


Table of Content
List of Figures Number of Products under
Development for Pulmonary Hypertension, H2 2015
16 Number of Products under Development for
Pulmonary Hypertension - Comparative Analysis, H2
2015 17 Number of Products under Development by
Companies, H2 2015 18 Number of Products under
Investigation by Universities/Institutes, H2 2015
23 Comparative Analysis by Late Stage
Development, H2 2015 24 Comparative Analysis by
Clinical Stage Development, H2 2015
25 Comparative Analysis by Early Stage Products,
H2 2015 26 Assessment by Monotherapy Products, H2
2015 79 Number of Products by Top 10 Targets, H2
2015 81 Number of Products by Stage and Top 10
Targets, H2 2015 81 Number of Products by Top 10
Mechanism of Actions, H2 2015 85 Number of
Products by Stage and Top 10 Mechanism of
Actions, H2 2015 85 Number of Products by Top 10
Routes of Administration, H2 2015 88 Number of
Products by Stage and Top 10 Routes of
Administration, H2 2015 88 Number of Products by
Top 10 Molecule Types, H2 2015 90 Number of
Products by Stage and Top 10 Molecule Types, H2
2015 90
4


Report Overview
Reasons to buy Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Pulmonary Hypertension Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline Devise
corrective measures for pipeline projects by
understanding Pulmonary Hypertension pipeline
depth and focus of Indication therapeutics Develop
and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and Scope Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline Enquire At
http//www.researchbeam.com/pulmonary-hypertension
-pipeline-review-h2-2015-market/enquire-about-repo
rt
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/pulmonary-hypertension
-pipeline-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com